Article in Journal of the American Society of Nephrology : JASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
Francesca ZanoniDepartment of Nephrology, Dialysis, and Kidney Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.ORCID 0000-0001-9567-6713
Maddalena MarasaDivision of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.ORCID 0000-0003-0712-2329
Lucrezia CarlassaraDivision of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.
Miguel VerbitskyDivision of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.ORCID 0000-0002-7066-0552
Atlas KhanDivision of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.ORCID 0000-0002-6651-2725
Chen WangDivision of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.ORCID 0000-0001-9127-0054
Joshua D BundyDepartment of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana.ORCID 0000-0002-6054-2624
Pietro A CanettaDivision of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.ORCID 0000-0003-1130-5486
Andrew S BombackDivision of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.ORCID 0000-0001-5449-1667
Afshin ParsaDivision of Kidney, Urologic and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.
Harold I FeldmanDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.ORCID 0000-0003-4572-2608
Ali G GharaviDivision of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.ORCID 0000-0003-2801-233
Krzysztof KirylukDivision of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York.ORCID 0000-0002-5047-6715
CRIC Study Investigators and the CureGN Study
Funding
Continuation of the Coordinating Center for the Chronic Renal Insufficiency Cohort (CRIC) StudyU24DK060990 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Amanda Hyre Anderson, Laura M Dember · 2018 to 2026
$21.5M
The Columbia PCC for CureGN: the Cure Glomerulonephropathy networkU01DK100876 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Andrew Stephen Bomback, ALI G GHARAVI · 2019 to 2026
$8.5M
CureGN-Penn PCCU01DK100846 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI LAWRENCE B. HOLZMAN · 2019 to 2026
$8.3M
Genomics of glomerular diseaseRC2DK116690 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KIRYLUK, KRZYSZTOF, KRETZLER, MATTHIAS · 2018 to 2022
$5.0M
Predictive utility of polygenic risk scores for chronic kidney disease.K25DK128563 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KHAN, ATLAS · 2021 to 2025
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Family History in the Context of CKD. · full record | OpenQuestion